Aref A, Thornton D, Youssef E, He T, Tekyi-Mensah S, Denton L, Ezzell G
Barbara Ann Karmanos Cancer Institute, Detroit, MI, USA.
Int J Radiat Oncol Biol Phys. 2000 Dec 1;48(5):1569-74. doi: 10.1016/s0360-3016(00)00808-7.
To evaluate the dosimetric difference between a simple radiation therapy plan utilizing a single contour and a more complex three-dimensional (3D) plan utilizing multiple contours, lung inhomogeneity correction, and dose-based compensators.
This is a study of the radiation therapy (RT) plans of 85 patients with early breast cancer. All patients were considered for breast-conserving management and treated by conventional tangential fields technique. Two plans were generated for each patient. The first RT plan was based on a single contour taken at the central axis and utilized two wedges. The second RT plan was generated by using the 3D planning system to design dose-based compensators after lung inhomogeneity correction had been made. The endpoints of the study were the comparison between the volumes receiving greater than 105% and greater than 110% of the reference dose, as well as the magnitude of the treated volume maximum dose. Dosimetric improvement was defined to be of significant value if the volume receiving > 105% of one plan was reduced by at least 50% with the absolute difference between the volumes being 5% or greater. The dosimetric improvements in 49 3D plans (58%) were considered of significant value. Patients' field separation and breast size did not predict the magnitude of improvement in dosimetry.
Dose-based compensator plans significantly reduced the volumes receiving > 105%, >110%, and volume maximum dose.
评估使用单一轮廓的简单放射治疗计划与使用多个轮廓、肺部不均匀性校正和基于剂量的补偿器的更复杂三维(3D)计划之间的剂量学差异。
这是一项对85例早期乳腺癌患者放射治疗(RT)计划的研究。所有患者均考虑保乳治疗,并采用传统切线野技术进行治疗。为每位患者生成两个计划。第一个RT计划基于在中心轴处获取的单一轮廓,并使用两个楔形板。第二个RT计划是在进行肺部不均匀性校正后,通过使用3D计划系统设计基于剂量的补偿器生成的。研究终点是比较接受大于参考剂量105%和大于110%的体积,以及治疗体积最大剂量的大小。如果一个计划中接受>105%的体积减少至少50%,且体积之间的绝对差异为5%或更大,则剂量学改善被定义为具有显著价值。49个3D计划(58%)中的剂量学改善被认为具有显著价值。患者的野间距和乳房大小并不能预测剂量学改善的程度。
基于剂量的补偿器计划显著减少了接受>105%、>110%的体积以及体积最大剂量。